GW is a Cambridge-based biopharmaceutical company that researches and markets cannabinoid medicine for the treatment of LGS and Dravet syndrome.
Business Model:
Revenue: $559M
Employees: 1,001-5,000
GW Pharmaceuticals was acquired by
Jazz Pharmaceuticals.
The acquisition happend on 2021-02-03.
Details of the transaction were not public
Address: Sovereign House
City: Cambridge
State: england
Zip: CB24 9BZ
Country: GB
GW is a Cambridge-based biopharmaceutical company that researches and markets cannabinoid medicine for the treatment of LGS and Dravet syndrome.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/1/2013
Ticker Symbol:
GWPH
Amount Raised:
$31M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2013 | IPO | $31M | 3/2017 | Post-IPO Equity | $0 |
Mentor Capital Mentor Capital |
12/2017 | Post-IPO Equity | $317.4M | 1/2014 | Post-IPO Equity | $87.9M | 4/2015 | Post-IPO Equity | $179.2M | 7/2016 | Post-IPO Equity | $289.8M | 10/2018 | Post-IPO Equity | $345.2M | 3/2017 | Post-IPO Equity | 1 | $1M |
Mentor Capital Mentor Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|